| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |